SlideShare a Scribd company logo
1 of 112
Download to read offline
Osteomyelitis, osteoarthritis,
Rheumatoid arthritis
Getu Mosisa(BSc, MSc).
11/15/2022
1
Objectives
11/15/2022
By Getu M( Bsc, Msc)
2
At the end of the session the students will able to:
 Describe osteomyelitis, osteo-arthritis, rheumatoid arthritis
 Describe patho-physiology of osteomyelitis, osteo-arthritis,
rheumatoid arthritis
 List clinical features of osteomyelitis, osteo-arthritis, rheumatoid
arthritis
 Identify managements of osteomyelitis, osteo-arthritis,
rheumatoid arthritis
 Develop nursing process for the patients with osteomyelitis,
osteo-arthritis, rheumatoid arthritis
Osteomyelitis
 Osteomyelitis is an infection of the bone.
PATHOPHYSIOLOGY
 Bone is normally resistant to infection.
 When microorganisms are introduced into bone
hematogenously from surrounding structures or from direct
inoculation related to surgery or trauma, osteomyelitis can
occur.
 Bone infection may result from the treatment of trauma, which
allows pathogens to enter bone and proliferate in the traumatized
tissue.
11/15/2022
3
Cont.…..
 When bone infection persists for months, the resulting infection is
referred to as chronic osteomyelitis and may be polymicrobial.
 Although all bones are subject to infection, the lower extremity is most
commonly involved.
Important factors in the pathogenesis of osteomyelitis include
the following:
 Virulence of the infecting organism
 Underlying disease
 Immune status of the host
 Type, location, and vascularity of the bone
11/15/2022
4
Cont.……
 Bacteria may possess various factors that may contribute to
the development of osteomyelitis.
 For example, factors promoted by S aureus may promote
bacterial adherence, resistance to host defense mechanisms,
and proteolytic activity
11/15/2022
5
Cont.……
Hematogenous osteomyelitis
 In adults, the vertebrae are the most common site of
hematogenous osteomyelitis, but infection may also occur in
the long bones, pelvis, and clavicle.
 Primary hematogenous osteomyelitis is more common in
infants and children, usually occurring in the long-bone
metaphysis; it may spread to the medullary canal or into the
joint.
 Secondary hematogenous osteomyelitis is more common
and can develop from any primary focus of infection or from
reactivation of a previous infection in the presence of
immuno-compromised status.
11/15/2022
6
Contiguous-focus and posttraumatic osteomyelitis
 The initiating factor in contiguous-focus
osteomyelitis often consists of:
 Direct inoculation of bacteria via trauma,
 Surgical reduction and internal fixation of fractures,
prosthetic devices,
 Spread from soft-tissue infection,
 Spread from adjacent septic arthritis, or nosocomial
contamination.
 Infection usually results approximately 1 month after
inoculation.
11/15/2022
7
Cont.……
 Posttraumatic osteomyelitis more commonly affects adults and
typically occurs in the tibia.
 The most commonly isolated organism is S aureus.
 At the same time, local soft-tissue vascularity may be compromised,
leading to interference with healing.
 Compared with hematogenous infection, posttraumatic infection begins
outside the bony cortex and works its way in toward the medullary
canal.
 Low-grade fever, drainage, and pain may be present.
 Loss of bone stability, necrosis, and soft-tissue damage may lead to a
greater risk of recurrence
11/15/2022
8
Cont.……
 Septic arthritis may lead to osteomyelitis.
 Abnormalities at the joint margins or centrally, which may arise
from overgrowth and hypertrophy of the synovial pannus and
granulation tissue,
 may eventually extend into the underlying bone, leading to
erosions and osteomyelitis.
 One study demonstrated that septic arthritis in elderly persons
most commonly involves the knee and that, despite most of the
patients having a history of surgery, 38% developed osteomyelitis.
 Many patients with vascular compromise, as in diabetes mellitus,
are predisposed to osteomyelitis owing to an inadequate local
tissue response
11/15/2022
9
Cont.……
 Infection in neuropathic or vascular-compromised feet is most
often caused by minor trauma to the feet with multiple organisms
isolated from bone,
 including Streptococcus species, Enterococcus species, coagulase-positive
and -negative staphylococci, gram-negative bacilli, and anaerobic
organisms.
 Fungal infections are also known in neuropathic feet with
osteomyelitis.
 Foot ulcers allow bacteria to reach the bone.
 Patients may not experience any resulting pain, because of
peripheral neuropathy, and may present with a perforating foot
ulcer, cellulitis, or an ingrown toenail.
 Treatment of osteomyelitis in diabetic feet is multidisciplinary and
prolonged, involving complex debridements, soft-tissue cover, and
antimicrobial and antifungal treatments.
11/15/2022
10
Vertebral osteomyelitis
 The incidence of vertebral osteomyelitis generally increases
progressively with age, with most affected patients being older
than 50 years
 The infection usually originates hematogenously and generally
involves two adjacent vertebrae with the corresponding
intervertebral disk.
 The lumbar spine is most commonly affected, followed by the
thoracic and cervical regions.
 Potential sources of infection include skin, soft tissue, respiratory
tract, genitourinary tract, infected intravenous (IV) sites, and dental
infections.
 S aureus is the most commonly isolated organism.
 However, Pseudomonas aeruginosa is more common in IV drug
users.
11/15/2022
11
Cont.……
 Most patients with vertebral osteomyelitis present with localized
pain and tenderness of the involved vertebrae with a slow
progression over 3 weeks to 3 months.
 Fever may be present in approximately 50% of patients.
 Some 15% of patients may have motor and sensory deficits.
 Laboratory studies may reveal peripheral leukocytosis and an
elevated erythrocyte sedimentation rate (ESR).
 Extension of the infection may lead to abscess formation.
11/15/2022
12
Etiology
 The major causes of osteomyelitis include the following:
 Primary - Hematogenous
 Secondary - Secondary to trauma, surgery, or sepsis of
any etiology
11/15/2022
13
Risk factors
 Poorly nourished
 Elderly
 Obese
 Impaired immune system (long-term corticosteroid therapy or
immunosuppressive agents)
 Chronic illness (diabetes, rheumatoid arthritis)
 History of previous injury or infection
 Postoperative
11/15/2022
14
Epidemiology
 Approximately 20% of adult cases of osteomyelitis are
hematogenous, which is more common in males for unknown
reasons.
 The overall incidence of vertebral osteomyelitis is believed to
have increased as a consequence of IV drug use, increasing age of
the population, and higher rates of nosocomial infection due to
intravascular devices and other instrumentation.
 The overall incidence of osteomyelitis is higher in developing
countries.
11/15/2022
15
Presentation
History
 Acute osteomyelitis requires that the clinician maintain a high
degree of suspicion so as to minimize delayed diagnosis and the
consequences.
 Osteomyelitis is often diagnosed clinically on the basis of
nonspecific symptoms such as fever, chills, fatigue, lethargy, or
irritability.
 The classic signs of inflammation, including local pain, swelling, or
redness, may also occur and usually disappear within 5-7 days
11/15/2022
16
Cont.……
 Chronic posttraumatic osteomyelitis requires a detailed
history for diagnosis, including information regarding the
initial injury and previous antibiotic and surgical
treatment.
 Weightbearing and function of the involved extremity are
typically disturbed.
 Local pain, swelling, erythema, and edema may also be
reported
11/15/2022
17
Physical examination
 On physical examination, scars or local disturbance of wound
healing may be noted along with the cardinal signs of
inflammation.
 Range of motion ROM), deformity, and local signs of impaired
vascularity are also sought in the involved extremity
11/15/2022
18
DIAGNOSTIC METHODS
 A complete blood count (CBC) is useful for evaluating
leukocytosis and anemia.
 Leukocytosis is common in acute osteomyelitis before therapy.
The leukocyte count rarely exceeds 15,000/µL acutely and is
usually normal in chronic osteomyelitis.
 The erythrocyte sedimentation rate (ESR) and the C-reactive
protein (CRP) level are usually increased.
 Alkaline phosphatase (ALP), calcium, and phosphate are elevated,
but they are within normal limits in osteomyelitis.
11/15/2022
19
Cont.……
 Blood cultures are positive in only 50% of cases of
osteomyelitis.
 They should be obtained before or at least 48 hours after
antibiotic treatment.
11/15/2022
20
Imaging studies
Radiography
 Conventional radiography is the initial imaging study at
presentation of acute osteomyelitis.
 Radiographic findings include periosteal thickening or elevation, as
well as cortical thickening, sclerosis, and irregularity.
 Other changes include loss of trabecular architecture, osteolysis,
and new bone formation.
 These changes may not be evident until 5-7 days in children and
10-14 days in adults.
 Plain films show lytic changes after at least 50-75% of the bone
matrix is destroyed.
 Therefore, negative radiographic studies do not exclude the
diagnosis of acute osteomyelitis.
11/15/2022
21
Cont.……
 Computed tomography (CT) is useful for guiding needle
biopsies in closed infections and for preoperative planning
to detect osseous abnormalities, foreign bodies, or necrotic
bone and soft tissue.
 It may assist in the assessment of bony integrity, cortical
disruption, and soft-tissue involvement. It may also reveal
edema
 Magnetic resonance imaging (MRI) is a very useful modality
in detecting osteomyelitis and gauging the success of
therapy because of its high sensitivity and excellent spatial
resolution.
 The extent and location of osteomyelitis is demonstrated
along with pathologic changes of bone marrow and soft
tissue
11/15/2022
22
Cont.……
 Bone biopsy leads to a definitive diagnosis by isolation of
pathogens directly from the bone lesion.
 Bone biopsy should be performed through uninfected tissue
and either before the initiation of antibiotics or more than
48 hours after discontinuance.
 Open or percutaneous needle bone biopsy with
histopathologic examination and culture is the routine for
the diagnosis of osteomyelitis.
 This procedure may not be necessary if blood cultures are
positive with consistent radiologic findings
11/15/2022
23
Treatment
 The principles of management of osteomyelitis necessitate a
multipronged, multidisciplinary approach that may involve a team
consisting of the following:
 Orthopedic surgeon
 Infectious disease consultant
 Plastic surgeon
 Microbiologist
 Nurses
 Others as needed
11/15/2022
24
Cont.……
 This approach should first determine whether the disease is
acute, chronic, or an acute exacerbation of a chronic disease
or (in some cases) a partially treated subacute osteomyelitis.
 Acute osteomyelitis must be treated surgically to drain pus
and prevent bone necrosis.
 Antibiotics suited to the patient's age and the organism are
given to control hematogenous spread and to treat the local
infection.
 In other words, antibiotics save life, and surgery helps save
bone.
 Debridement of necrotic tissues, removal of foreign materials,
and sometimes skin closure of chronic unhealed wounds are
necessary in some cases.
11/15/2022
25
Differential Diagnoses
 Ewing Sarcoma
 Gout and Pseudogout
 Septic Arthritis
 Sickle Cell Disease (SCD)
11/15/2022
26
Medical Therapy
 Antibiotic treatment should be based on the identification
of pathogens from bone cultures at the time of bone biopsy
or debridement
 Bone cultures are obtained first, and suspected pathogens
are then covered by initiation of a parenteral antimicrobial
treatment.
 However, treatment may be modified once the organism is
identified.
 Parenteral and oral antibiotics may be used alone or in
combination, depending on microorganism sensitivity
results, patient compliance, and infectious disease
consultation.
11/15/2022
27
Cont.……
 Traditionally, antibiotic treatment of osteomyelitis has
consisted of a 4- to 6-week course.
 Animal studies and observations show that bone
revascularization following debridement takes about 4 weeks.
 However, if all infected bone is removed, as in forefoot
osteomyelitis, antibiotic therapy can be shortened to 10 days
 Oral antibiotics that have been proved to be effective include
clindamycin, rifampin, trimethoprim-sulfamethoxazole, and
fluoroquinolones.
11/15/2022
28
Cont.……
 Clindamycin is given orally after initial intravenous (IV)
treatment for 1-2 weeks and has excellent bioavailability.
 It is active against most gram-positive bacteria, including
staphylococci.
 Linezolid is active against methicillin-resistant
staphylococci and vancomycin-resistant Enterococcus.
 It inhibits bacterial protein synthesis, has excellent bone
penetration, and is administered IV or orally.
11/15/2022
29
Cont.……
 Oral quinolones are often used in adults for gram-negative
organisms.
 Quinolones have excellent oral absorption and may be used as
soon as patient is able to take them.
 Rifampin has an optimal intercellular concentration and a good
sensitivity profile for methicillin-resistant staphylococci.
 It is used in combination with cell wall–active antibiotics to
achieve synergistic killing and to avoid rapid emergence of
resistant strains.
11/15/2022
30
Cont.……
 The use of rifampin in combination with other antibiotics has
been found to be more effective than monotherapy for treating
infection associated with surgical hardware.
 Extensive studies of suppressive therapy with administration of
rifampin, ofloxacin, fusidic acid, and trimethoprim-
sulfamethoxazole for 6-9 months have been performed in patients
with infected orthopedic implants.
 Studies have shown that, after discontinuance of antibiotics, no
recurrence of infection occurred in 67% of patients treated with
trimethoprim-sulfamethoxazole, 55% of patients treated with
rifampin and fusidic acid, and 50% of patients treated with
rifampin and ofloxacin.
11/15/2022
31
Surgical Management
 Surgical debridement of bone to remove purulent and necrotic
material followed by irrigation is performed; IV antibiotics are
continued.
 Antibiotic-impregnated beads may be placed directly in the
wound.
 Chronic osteomyelitis: Sequestrectomy (removal of necrotic
bone) is performed, with sufficient bone removed to convert a
deep cavity into a shallow saucer (saucerization).
 Closed suction irrigation system may be used to remove debris.
 Wound irrigation using sterile physiologic saline solution may be
performed for 7 to 8 days.
11/15/2022
32
Cont.…..
 Wounds are closed tightly to obliterate the dead space or
packed and closed later by granulation or grafting with
muscle flap.
 Internal fixation or external supportive devices may be
needed to stabilize or support the bone to prevent
pathologic fracture.
11/15/2022
33
Nursing process with patient with osteomyelitis
Assessment
 Assess for risk factors (eg, older age, diabetes, long-term
steroid therapy) and for previous injury, infection, or
orthopedic surgery.
 Assess for acute onset of signs and symptoms (e.g.
localized pain, edema, erythema, fever) or recurrent drainage
of an infected sinus with associated pain, edema, and low-
grade fever.
 Observe for guarding or patient avoiding pressure on area.
11/15/2022
34
Cont.…..
 Assess for generalized weakness due to systemic
reaction to infection.
 Observe for inflammation, edema, tenderness, and purulent
drainage.
 Monitor for elevated temperature.
 Patients with chronic osteomyelitis may have minimal
temperature elevations, occurring in the afternoon or
evening
11/15/2022
35
Nursing Diagnoses
 Acute pain related to inflammation and edema
 Impaired physical mobility related to pain, immobilization
devices, and weight-bearing limitations
 Risk for extension of infection: Bone abscess formation
 Deficient knowledge about treatment regimen
11/15/2022
36
Planning
 Goals include:-
 Relief of pain,
 Improved physical mobility within therapeutic
limitations, control and
 Eradication of infection, and knowledge of the
treatment regimen.
11/15/2022
37
Nursing Interventions
Relieving Pain
 Splint affected area to decrease pain and muscle spasm.
 Monitor neurovascular status of affected extremity
 Handle affected part with great care to avoid pain.
• Elevate affected part to reduce swelling and discomfort.
• Administer prescribed analgesics in conjunction with other
techniques to reduce pain
11/15/2022
38
Cont.…..
Improving Physical Mobility
 Teach patient to adhere to activity restrictions and
reduce stress on the bone, as bone is weakened due to
infectious process.
 Encourage activities of daily living within physical
limitations.
11/15/2022
39
Cont.…..
 Controlling Infectious Process
• Monitor response to antibiotic therapy. Observe IV sites
for evidence of phlebitis, infection, or infiltration.
• Monitor for signs of super-infection, such as oral or vaginal
candidiasis, and loose or foul-smelling stools, secondary to
long-term antibiotic therapy.
11/15/2022
40
Cont.…..
 If surgery is necessary, maintain wound suction, elevation
of area, avoidance of pressure on grafted area; maintain
immobility and compliance with weight-bearing
restrictions.
 Change dressings using aseptic technique to promote
healing and prevent cross-contamination.
 Monitor general health and nutrition; provide a diet high
in protein and vitamin C to promote positive nitrogen
balance and healing; encourage adequate hydration
11/15/2022
41
Cont.…..
Teaching Patients Self-Care
 Teach patient and family to adhere strictly to the antibiotics
regimen and to prevent falls or other injuries that could result in
fracture.
 Teach patient and family how to maintain and manage the IV
access site and IV administration equipment.
 Provide education about medication name, dosage, frequency,
administration rate, safe storage and handling, adverse reactions,
and necessary laboratory monitoring.
11/15/2022
42
Cont.…..
 Teach about aseptic dressing and warm compress
techniques.
 Monitor for and instruct patient to report elevated
temperature, drainage, odor, signs of increased
inflammation, adverse reactions, and signs of super-
infection.
 Assess need for home care or home infusion.
 Stress importance of follow-up health care appointments
and recommend age-appropriate health screening
11/15/2022
43
Evaluation
Expected Patient Outcomes
• Experiences pain relief
• Increases physical mobility
• Has absence of infection; negative wound cultures,
normalWBCs
• Adheres to therapeutic plan
11/15/2022
44
Osteoarthritis
 Osteoarthritis (OA) is the most common type of arthritis.
 Its high prevalence, especially in the elderly, and its negative
impact on physical function make it a leading cause of
disability in the elderly
 OA has been classified as primary (idiopathic), with no
prior event or disease related to the OA, and secondary,
resulting from previous joint injury or inflammatory disease.
 The distinction between primary and secondary OA is not
always clear.
11/15/2022
45
Cont.…….
Commonly affected joints include
 The hip, knee, and first metatarsal phalangeal joint (MTP) and
cervical and lumbosacral spine.
 In the hands, the distal and proximal inter-phalangeal joints
and the base of the thumb are often affected.
 Usually spared are the wrist, elbow, and ankle.
 OA often begins in the third decade of life and peaks
between the fifth and sixth decades.
11/15/2022
46
Joints commonly affected by osteoarthritis
11/15/2022
47
Epidemiology
 Studies continue to illustrate the high prevalence of OA
worldwide, with a greater burden among:-
 older individuals, women, some racial and ethnic groups, and individuals
with lower socioeconomic status
 Statistical figures are influenced by how the condition is defined—
that is, by self-report, by radiographic or symptomatic criteria, or
by a combination of these.
 On the basis of the radiographic criteria for osteoarthritis, more
50% of adults older than 65 years are affected by the disease.
 Internationally, osteoarthritis is the most common articular
disease.
 Estimates of its frequency vary across different populations.
11/15/2022
48
Cont.…..
11/15/2022
49
Age-related demographics
 Primary osteoarthritis is a common disorder of the elderly,
and patients may present asymptomatic.
 Approximately 80-90% of individuals older than 65 years
have evidence of radiographic primary osteoarthritis
 The prevalence of the disease increases dramatically among
persons older than 50 years.Why?
 Because of age-related alterations in collagen and
proteoglycans that decrease the tensile strength of the
joint cartilage and because of a diminished nutrient supply
to the cartilage
11/15/2022
50
Sex related characteristics
 In individuals older than 55 years, the prevalence of osteoarthritis
is higher among women than among men.
 Women are especially susceptible to osteoarthritis in the DIP
joints of the fingers.
 Women also have osteoarthritis of the knee joints more
frequently than men do, with a female-to-male incidence ratio of
1.7:1.
 Women are also more prone to erosive osteoarthritis, with
a female-to-male ratio of about 12:1.
11/15/2022
51
Race-related demographics
 In persons older than 65 years, osteoarthritis is more
common in whites than in blacks.
 Knee osteoarthritis appears to be more common in black
women than in other groups.
11/15/2022
52
RISK FACTORS
 Joint vulnerability and joint loading are the two major factors
contributing to the development of OA.
 On the one hand, a vulnerable joint whose protectors are
dysfunctional can develop OA with minimal levels of loading,
perhaps even levels encountered during everyday activities.
 On the other hand, in a young joint with competent protectors, a
major acute injury or long-term overloading is necessary to
precipitate disease.
 Risk factors for OA can be understood in terms of their effect
either on joint vulnerability or on loading
11/15/2022
53
Risk factors for osteoarthritis (OA) either contribute to the susceptibility of the joint
(systemic factors or factors in the local joint environment) or increase risk by the load they
put on the joint. Usually, a combination of loading and susceptibility factors is required to
cause disease or its progression.
11/15/2022
54
PATHOPHYSIOLOGY
 OA falls into two major etiologic classes.
 Primary (idiopathic) OA, the more common type, has no identifiable
cause.
 Secondary OA is associated with a known cause such as
rheumatoid or another inflammatory arthritis, trauma, metabolic
or endocrine disorders, and congenital factors
 The old view of OA as a “wear-and-tear” or degenerative disease,
largely focused on joint cartilage, has long been superseded by an
appreciation of the dynamic nature of OA and that it represents a
failure of the joint and surrounding tissues.
 Some changes in the OA joint may reflect compensatory
processes to maintain function in the face of ongoing joint
destruction.
 Not only biomechanical forces but also inflammatory, biochemical,
and immunologic factors are involved.
11/15/2022
55
Function, Structure, and Composition of
Cartilage
 Articular cartilage possesses viscoelastic properties that
provide lubrication with motion, shock absorbency during
rapid movements, and load support.
 In synovial joints, articular cartilage is found between the
synovial cavity on one side and a narrow layer of calcified
tissue overlying subchondral bone on the other side
 The layer of cartilage is narrow, with human medial femoral
articular cartilage being approximately 2 to 3 mm thick.
 Despite this, healthy articular cartilage in weight-bearing
joints withstands millions of cycles of loading and unloading
each year.
 Cartilage is easily compressed, losing up to 40% of its
original height when a load is applied.
11/15/2022
56
Cont.…..
 Compression increases the area of contact and disperses
force more evenly to underlying bone, tendons ligaments,
and muscles.
 In addition, cartilage is almost frictionless, and together with
its compressibility, this enables smooth movement in the
joint, distributes load across joint tissues to
prevent damage, and stabilizes the joint
11/15/2022
57
Cont.…..
 Normal cartilage turnover helps repair and restore cartilage in
response to demands of joint loading and during physical activity.
 In adults, cartilage chondrocyte metabolism is slow and is
regulated by growth factors, including bone morphogenetic
protein 2, insulin-like growth factor-1, and transforming growth
factor, and by catabolism and proteolysis stimulated by matrix
metalloproteinases (MMPs), tumor necrosis factor-α (TNF-α),
interleukin-1, and other cytokines.
 Tissue inhibitors of metalloproteinase (TIMP) also contribute to
the balance by restraining the catabolic actions of MMPs.
 If cartilage is injured, chondrocytes react by removing the
damaged areas and increasing synthesis of matrix constituents to
repair and restore cartilage
11/15/2022
58
Cont.…..
 Another component supporting healthy joints are the joint
protective mechanisms,
 such as muscles bridging the joint, sensory receptors in feedback
loops to regulate muscle and tendon function, supporting
ligaments, and subchondral bone that has shock-absorbent
properties.
 Finally, it is important to note that adult articular cartilage is
avascular, with chondrocytes nourished by synovial fluid.
 With movement and cyclic loading and unloading of joints,
nutrients flow into the cartilage, whereas immobilization
reduces nutrient supply.
 This is one of the reasons that normal physical activity is
beneficial for joint health.
11/15/2022
59
Characteristics of osteoarthritis in the diarthrodial joint
11/15/2022
60
Osteoarthritic Cartilage
 Important contributors to the development of OA are
local mechanical influences, genetic factors,
inflammation, and aberrant chondrocyte function leading to
loss of articular cartilage.
 At a molecular level, OA pathophysiology involves the
interplay of dozens, if not hundreds, of extracellular
and intracellular molecules with roles including:
 chondrocyte regulation, phenotypic changes, proteolytic
degradation of cartilage components, and interactions between
articular cartilage, underlying subchondral bone, and the joint
synovium.
11/15/2022
61
Cont.…..
 OA most commonly begins with damage to articular cartilage,
through trauma or other injury, excess joint loading from obesity
or other reasons, or instability or injury of the joint that causes
abnormal loading.
 In response to cartilage damage, chondrocyte activity increases in
an attempt to remove and repair the damage.
 Depending on the degree of damage, the balance between
breakdown and re-synthesis of cartilage can be lost, and a vicious
cycle of increasing breakdown can lead to further
cartilage loss and apoptosis of chondrocytes
11/15/2022
62
Cont.…..
 There is an increased appreciation of the role of tissues beyond
cartilage, within the joint and surrounding it, subchondral bone.
 Subchondral bone undergoes pathologic changes that may
precede, coincide with, or follow damage to the articular
cartilage.
 In OA, subchondral bone releases vasoactive peptides and
MMPs, and damage to subchondral bone may trigger further
damage to articular cartilage.
 Neovascularization and subsequent increased permeability of
the adjacent cartilage occur and contributes further to cartilage
loss.
 Joint space narrowing resulting from loss of cartilage can lead to
a painful and deformed joint.
11/15/2022
64
Cont.…..
 Remaining cartilage softens and develops fibrillations (vertical
clefts into the cartilage), followed by splitting off more cartilage
and exposure of underlying bone.
 During this time, adjacent subchondral bone undergoes further
pathologic changes, cartilage is eroded completely, leaving
denuded subchondral bone, which becomes dense, smooth, and
glistening (eburnation).
 A more brittle, stiffer bone results, with decreased weight-bearing
ability and development of sclerosis and microfractures.
 New bone formations, or osteophytes, also appear at joint
margins, distant from cartilage destruction and are thought to
arise from local and humoral factors.
 There is direct evidence that osteophytes can help stabilize
osteoarthritic joints
11/15/2022
65
Cont.…..
 In the joint capsule and synovium, inflammatory changes and
pathologic changes can occur.
 Contributors to inflammation may include crystals or cartilage
shards in synovial fluid.
 Other possible players are interleukin-1, prostaglandin E2, TNF-α,
and nitric oxide which are found in synovial fluid.
 With inflammatory changes in the synovium, effusions and
synovial thickening occur.
 The pain of OA is not related to the destruction of cartilage but
arises from the activation of nociceptive nerve endings within the
joint by mechanical and chemical irritants.
 OA pain may result from distension of the synovial capsule by
increased joint fluid, microfracture, periosteal irritation, or
damage to ligaments, synovium, or the meniscus.
11/15/2022
66
SOURCES OF PAIN
 Because healthy cartilage is aneural, cartilage loss alone in a joint
is not accompanied by pain.
 Thus, pain in OA likely arises from structures outside the
cartilage.
 Innervated structures in the joint include the synovium, ligaments,
joint capsule, muscles, and subchondral bone.
 Most of these are not visualized by x-ray, and the severity of x-ray
changes in OA correlates poorly with pain severity.
 However, in later stages of OA, loss of cartilage integrity
accompanied by neurovascular invasion may contribute to pain
11/15/2022
67
Diagnosis
 The diagnosis of OA is made through history, physical
examination, characteristic radiographic findings, and
laboratory testing.
 The major diagnostic goals are:
1. To discriminate between primary and secondary OA and
2. To clarify the joints involved, severity of joint
involvement, and response to prior therapies, providing a
basis for a treatment plan
11/15/2022
68
Cont.…..
 The American College of Rheumatology has published
traditional diagnostic criteria and “decision trees” for OA
diagnosis.
 As with all guidelines, the authors stress these are for
assisting the clinician rather than replacing clinical judgment.
 For example, traditional criteria are as follows:
 (1) For hip OA, a patient must have pain in the hip and at
least two of the following three: an erythrocyte
sedimentation rate less than 20 mm/h (<5.6 µm/s), femoral
or acetabular osteophytes on radiography, or joint space
narrowing on radiography.
 This provides a sensitivity of 89% and a specificity of 91%.
11/15/2022
69
Cont.…..
2. For a clinical diagnosis of knee OA, a patient
must have
 Pain at the knee and osteophytes on radiography
 Plus one of the following: age older than 50 years, morning
stiffness not more than 30 minutes, crepitus on motion, bony
enlargement, bony tenderness, or palpable warmth.
 This provides a sensitivity of 95% and a specificity of 69%.
 The addition of laboratory or radiographic data further
improves accuracy of diagnosis
11/15/2022
70
Clinical features
Symptoms
 Pain
 Deep, aching character
 Pain on motion
 Stiffness in affected joints
 Resolves with motion, recurs with
rest (“gelling phenomenon”)
 Usually duration <30 minutes
 Often related to weather
 Limited joint motion
 May result in limitations of
activities of daily living
 Instability of weight-bearing joints
Signs, history, and physical
examination
 Monoarticular or oligoarticular,
asymmetrical involvement
 Hands
 Distal interphalangeal joints
Herberden nodes (osteophytes or
bony enlargements)
 Proximal interphalangeal joints
Bouchard’s nodes (osteophytes)
First metacarpal joint
 Osteophytes give characteristic
square appearance to hands
11/15/2022
71
Cont.…..
 Knee
Pain related to climbing
stairs
Transient joint effusion
Genu varum (“bow-legged”)
 Hips
Groin pain during weight
bearing exercises
Stiffness, especially after
activity
Limited joint movement
 Spine
Lumbar involvement is most
common at L3 and L4
Paresthesias
Loss of reflexes
 Feet
Typically involves the first
metatarsalphalangeal joint
Shoulder, elbow,
acromioclavicular,
sternoclavicular,
tempomandibular joints may
also be affected
 Observation on joint
examination
Bony proliferation or occasional
synovitis
Local tenderness
Crepitus
Limited motion with
passive/active movement
Deformity
11/15/2022
72
Cont.…..
 Radiologic Evaluation
 Early Mild OA
 Radiographic changes often absent
 Progressive OA
 Joint space narrowing
 Subchondral bone sclerosis
 Marginal osteophytes
 Late OA
Abnormal alignment of joints
Effusions
11/15/2022
73
Desired Outcome
 Management of the patient with OA begins with a diagnosis
based on a careful history, physical examination, radiographic
findings, and an assessment of the extent of joint
involvement.
 Treatment should be tailored to each individual.
Goals are
A. To educate the patient, family members, and
caregivers;
B. To relieve pain and stiffness;
C. To maintain or improve joint mobility;
D. To limit functional impairment; and
E. To maintain or improve quality of life
11/15/2022
74
Treatment
 Non pharmacologic
– Encourage weight reduction if obese or overweight
– Increase physical activity, specific exercise, physiotherapy
– Weight supports (crutches, walking sticks or frames)
– Arthroscopic interventions (irrigations, debridement and
synovectomy) in refractory cases
11/15/2022
75
Cont.…..
11/15/2022
76
11/15/2022
77
Pharmacologic treatment
Pain management
Inflammatory osteoarthritis
First line-NSAIDS,
 Ibuprofen, 200-400mg P.O.,TID
 Diclofenac, 50-75mg P.O., BID or rectal suppository 100mg/daily
 Indomethacin, 25-50mg, P.O., 2-3 times/day; maximum dose is
200mg/day or rectal suppository 100mg/daily.
 Avoid indomethacin in hip OA.
 Piroxicam, 10-20mg, P.O., once per day. Maximum dose is
20mg/day
 Dosage forms: Capsule, 10mg, 20mg ;Tablet, 10mg, 20mg
 Meloxicam, 7.5-15mg/day. Maximum dose is 15 mg/day
 Dosage forms:Tablet, 7.5mg, 15mg
11/15/2022
78
Cont.….
Plus
 GI protection for high risk individuals: a history of peptic ulcer
disease, on antiplatelet therapy, concomitant anticoagulant
therapy, or have more than one of other risk factors (Age ≥60
years, Corticosteroid use, Dyspepsia or GERD symptoms)
 First line PPIs
Omeprazole, 20mg, P.O., once daily or BID.
Esomeprazole, 20-40mg, P.O., once daily
Pantoprazole, 40mg, P.O., once daily
 Alternative-H2 blockers
Cimetidine, 400mg P.O., BID
Ranitidine, 150mg, P.O, BID
11/15/2022
79
Non inflammatory osteoarthritis
 First line
 Paracetamol, 1g 4–6 hourly P.O., when required to a
maximum of 4 doses per 24 hours
If ineffective: start NSAIDS as above.
 First line
 Tramadol, 50mg to 100mg, P.O., once to twice per day.
Dosage forms: tablet/capsule, 50mg, 75mg, 100mg, 200mg
 Alternative
 Codeine phosphate 30mg P.O., QID. USE CODEINE FOR
SHORT DURATION ONLY.
Dosage forms: Tablet 30mg
11/15/2022
80
Cont.…..
Intra-articular steroids
– Consider in inflammatory osteoarthritis of the knee and
shoulder when it is refractory to NSAIDS
– To be prescribed and administered by a specialist only
– Not more than 2–3 injections per year per joint are
recommended.
First line
Methylprednisolone acetate, 20–80mg depending on joint
size
 Dosage forms: Injection, 40mg/ml in 1ml ampoule
11/15/2022
81
Cont.…..
OR
 Triamcinolone acetonide: Initial: Smaller joints: 2.5-
5mg, larger joints: 5-15mg, up to 40mg for large joints
Dosage forms: Injection, 10mg/ml, 40mg/ml in vial
11/15/2022
82
Rheumatoid arthritis
 Rheumatoid arthritis (RA) is the most common systemic
inflammatory disease characterized by symmetrical joint
involvement.
 Extra-articular involvement, including rheumatoid nodules,
vasculitis, eye inflammation, neurologic dysfunction,
cardiopulmonary disease, lymphadenopathy, and
splenomegaly, can be manifestations of the disease.
11/15/2022
83
Epidemiology
 RA affects ∼0.5–1% of the adult population worldwide
 It can occur at any age, with increasing prevalence up to
the seventh decade of life.
 The disease is three times more common in women.
 In people aged 15 to 45 years, women predominate by a
ratio of 6:1; the sex ratio is approximately equal among
patients in the first decade of life and in those older than
60 years.
11/15/2022
84
Cont.…….
 Epidemiologic data suggest that a genetic predisposition and
exposure to unknown environmental factors may be necessary
for expression of the disease.
 The major histocompatibility complex molecules, located on T
lymphocytes, appear to have an important role in most patients
with RA.
 These molecules can be characterized using human lymphocyte
antigen (HLA) typing.
 A majority of patients with RA have HLA-DR4, HLA-DR1, or
both antigens in the major histocompatibility complex region.
 Patients with HLA-DR4 antigen are 3.5 times more likely to
develop RA than those patients who have other HLA-DR
antigens
11/15/2022
85
Patho-physiology
 In RA, the autoimmune reaction primarily occurs in the
synovial tissue.
 Phagocytosis produces enzymes within the joint.
 The enzymes break down collagen, causing edema,
proliferation of the synovial membrane, and ultimately
pannus formation.
 Pannus destroys cartilage and erodes the bone.
 The consequence is loss of articular surfaces and joint
motion.
 Muscle fibers undergo degenerative changes.
 Tendon and ligament elasticity and contractile power are
lost
11/15/2022
86
Pathophysiology and associated physical signs of
rheumatoid arthritis. ROM, range of motion.
11/15/2022
87
RISK FACTORS
 Autoimmune
 RA affects 1% of the population worldwide, affecting
women two to four times more often than men
11/15/2022
88
Clinical features
 The incidence of RA increases between 25 and 55 years of age,
after which it plateaus until the age of 75 and then decreases.
 The presenting symptoms of RA typically result from inflammation
of the joints, tendons, and bursae.
 Patients often complain of early morning joint stiffness lasting >1
hour that eases with physical activity.
 The earliest involved joints are typically the small joints of the
hands and feet.
 The initial pattern of joint involvement may be monoarticular,
oligoarticular (≤4 joints), or polyarticular (>5 joints), usually in a
symmetric distribution.
 Some patients with inflammatory arthritis will present with too
few affected joints to be classified as having RA so-called
undifferentiated inflammatory arthritis.
11/15/2022
89
Extra articular manifestations
 Extra articular manifestations may develop during the clinical
course of RA in up to 40% of patients, even prior to the onset of
arthritis.
 Patients most likely to develop extraarticular disease have a history
of cigarette smoking, have early onset of significant physical
disability, and test positive for serum RF or Anti-Citrullinated
Protein Antibody (ACPA).
 Subcutaneous nodules, secondary Sjögren’s syndrome,
interstitial lung disease (ILD), pulmonary nodules, and anemia are
among the most frequently observed extraarticular manifestations.
11/15/2022
90
Extra articular manifestations
11/15/2022
91
Cont.……
 Subcutaneous nodules have been reported to occur in
30–40% of patients and more commonly in those with the
highest levels of disease activity, the disease-related shared
epitope (SE), a positive test for serum RF, and radiographic
evidence of joint erosions.
 Secondary Sjögren’s syndrome is defined by the
presence of either keratoconjunctivitis sicca (dry eyes) or
xerostomia (dry mouth) in association with another
connective tissue disease, such as RA.
 Approximately 10% of patients with RA have secondary
Sjögren’s syndrome
11/15/2022
92
Cont.…..
 Pleuritis, the most common pulmonary manifestation of RA,
may produce pleuritic chest pain and dyspnea, as well as a
pleural friction rub and effusion.
 The most frequent site of cardiac involvement in RA is the
pericardium.
 Up to 20% of patients with RA may have asymptomatic
pericardial effusions on echocardiography.
 Cardiomyopathy, another clinically important manifestation
of RA, may result from necrotizing or granulomatous
myocarditis, coronary artery disease, or diastolic
dysfunction
11/15/2022
93
Cont.…..
 Rheumatoid vasculitis typically occurs in patients with
long-standing disease, a positive test for serum RF or anti–
cyclic citrullinated peptide (CCP) antibodies, and
hypocomplementemia
 A normochromic, normocytic anemia often develops in
patients with RA and is the most common hematologic
abnormality.
 The degree of anemia parallels the degree of inflammation,
correlating with the levels of serum C-reactive protein (CRP)
and erythrocyte sedimentation rate (ESR).
 Platelet counts may also be elevated in RA as an acute-phase
reactant.
 Immune-mediated thrombocytopenia is rare in this disease.
11/15/2022
94
Cont.…..
 Felty’s syndrome is defined by the clinical triad of
neutropenia, splenomegaly, and nodular RA and is seen in
<1% of patients
 It typically occurs in the late stages of severe RA and is
more common in whites than other racial groups.
 Large cohort studies have shown a two- to fourfold
increased risk of lymphoma in RA patients compared with
the general population.
 The most common histopathologic type of lymphoma is a
diffuse large Bcell lymphoma.
 The risk of developing lymphoma increases if the
patient has high levels of disease activity or Felty’s
syndrome.
11/15/2022
95
Cont.…..
 Osteoporosis is more common in patients with RA than
an age- and sex-matched population, with an incidence
rate of nearly double that of the healthy population and a
prevalence of approximately one-third in postmenopausal
women with RA
11/15/2022
96
Investigations
- ESR/CRP
- Rheumatoid factor
- ANA (antinuclear antibody)
- X-ray of involved joints
11/15/2022
97
Treatment
 Objectives
- Reduce pain, swelling and stiffness
- Prevent deformities
- Delay disease progression and onset of long term
complications
11/15/2022
98
Treatment
 Non pharmacologic
- Rest of affected joints during acute flares
- Physiotherapy
11/15/2022
99
Pharmacologic
 Disease-modifying anti-rheumatic medicines (DMARD):
Initiate early in the course
First line
Methotrexate, 7.5mg P.O., once per week. Increase dose
gradually to a maximum of 25mg per week.
N.B. Monitor: Liver function and CBC before and 12 weekly
during treatment.
PLUS
Folic acid, 5mg P.O., per week with methotrexate at least 24
hours after the methotrexate dose
11/15/2022
100
Cont.…..
AND/OR
 Chloroquine phosphate, 150mg P.O., (as base) daily for 5
days of each week for 2–3 months.
 Then reduce dose if possible and administer 5 days a week
with an annual medicine holiday for 1 month.
 Do ophthalmic examination annually to monitor for ocular
damage.
AND/OR
Sulfasalazine, 500mg P.O., 12 hourly.
Gradually increase over one month from 500mg to 1 g 12
hourly.
 Liver function and CBCs monthly for first 3 months then
every 3–6 months
11/15/2022
101
Cont.…..
 Oral corticosteroids
Indications:
- As bridging therapy while waiting for DMARDs to take
effect.
- The elderly if threatened by functional dependence and
intolerant to NSAIDs.
- Extra-articular manifestations, e.g. pleural effusion, scleritis.
- Acute flare
Prednisolone, 40mg P.O., daily for 2 weeks during acute
flares.
 Thereafter gradually reduce the dose to < 7.5 mg daily.
 Maintenance low dose prednisolone may be needed in many
patients
11/15/2022
102
Joint pain management-NSAIDs
Use for active inflammation with pain.
NSAIDs are used for symptomatic control only, as they have no
long-term disease modifying effects.
NSAID dose should be reduced and then stopped once the
DMARDs have taken effect.
Ibuprofen, 800mg, P.O.,TID with meals. If not tolerated: 400mg 8
hourly.
An extra night-time dose of a NSAID may be added in some
patients with severe nocturnal pain/morning stiffness
OR
11/15/2022
103
Cont.…..
 Diclofenac, Immediate or delayed release tablet: 150-
200mg/day P.O., in 2-4 divided doses.
 Rectal suppository, insert 50mg or 100 mg rectally as single
dose to substitute for final daily dose (maximum combined
dose [rectal and oral]: 150 mg/day)
OR
Indomethacin, 25-50mg P.O., BIDTO TID; maximum dose:
200mg/day.
Rectal suppository, insert 100mg, BID or once, at bed time
11/15/2022
104
11/15/2022
105
11/15/2022
106
11/15/2022
107
11/15/2022
108
11/15/2022
109
11/15/2022
110
11/15/2022
111
11/15/2022
112
11/15/2022
113

More Related Content

Similar to Osteomyelitis, osteoarthritis, Rheumatoid arthritis.pdf

SEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTS
SEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTSSEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTS
SEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTSMarkone7
 
Principles of antibiotic use in management of osteomyelitis
Principles of antibiotic use in management of osteomyelitisPrinciples of antibiotic use in management of osteomyelitis
Principles of antibiotic use in management of osteomyelitisDr Aker Kenneth Ityo
 
Infection of bone
Infection of boneInfection of bone
Infection of boneOM VERMA
 
6-osteomylitis.pptx
6-osteomylitis.pptx6-osteomylitis.pptx
6-osteomylitis.pptxAhmedAbd66
 
Inflammatory disease of bones
Inflammatory disease of bonesInflammatory disease of bones
Inflammatory disease of bonesEneutron
 
Bone and Joint Infections PPT BY DR.BP .PPT
Bone and Joint Infections PPT BY DR.BP .PPTBone and Joint Infections PPT BY DR.BP .PPT
Bone and Joint Infections PPT BY DR.BP .PPTbharti pawar
 
Osteomyelitis_Inflammatory_bone_Diseases_ppt_53b2d7a41eaab7802c07486b411b0859...
Osteomyelitis_Inflammatory_bone_Diseases_ppt_53b2d7a41eaab7802c07486b411b0859...Osteomyelitis_Inflammatory_bone_Diseases_ppt_53b2d7a41eaab7802c07486b411b0859...
Osteomyelitis_Inflammatory_bone_Diseases_ppt_53b2d7a41eaab7802c07486b411b0859...fbbqbcht6y
 
Pyogenic bone and joint infections
Pyogenic bone and joint infectionsPyogenic bone and joint infections
Pyogenic bone and joint infectionsBajanagaraju
 
Osteomyelities.pptx
Osteomyelities.pptxOsteomyelities.pptx
Osteomyelities.pptxSachitaVerma
 
Seminar on chronic osteomyelitis sch
Seminar on chronic osteomyelitis schSeminar on chronic osteomyelitis sch
Seminar on chronic osteomyelitis schSharanayya Hiremath
 
Seminar on chronic osteomyelitis sch
Seminar on chronic osteomyelitis schSeminar on chronic osteomyelitis sch
Seminar on chronic osteomyelitis schSharanayya Hiremath
 

Similar to Osteomyelitis, osteoarthritis, Rheumatoid arthritis.pdf (20)

OSTEOMYELITIS.pdf
OSTEOMYELITIS.pdfOSTEOMYELITIS.pdf
OSTEOMYELITIS.pdf
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
Osteomylitis.pdf
Osteomylitis.pdfOsteomylitis.pdf
Osteomylitis.pdf
 
Acute osteomyelitis
Acute osteomyelitisAcute osteomyelitis
Acute osteomyelitis
 
SEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTS
SEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTSSEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTS
SEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTS
 
Principles of antibiotic use in management of osteomyelitis
Principles of antibiotic use in management of osteomyelitisPrinciples of antibiotic use in management of osteomyelitis
Principles of antibiotic use in management of osteomyelitis
 
Infection of bone
Infection of boneInfection of bone
Infection of bone
 
6-osteomylitis.pptx
6-osteomylitis.pptx6-osteomylitis.pptx
6-osteomylitis.pptx
 
Inflammatory disease of bones
Inflammatory disease of bonesInflammatory disease of bones
Inflammatory disease of bones
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
OSTEOMYELITIS
OSTEOMYELITISOSTEOMYELITIS
OSTEOMYELITIS
 
Bone and Joint Infections PPT BY DR.BP .PPT
Bone and Joint Infections PPT BY DR.BP .PPTBone and Joint Infections PPT BY DR.BP .PPT
Bone and Joint Infections PPT BY DR.BP .PPT
 
Osteomyelitis_Inflammatory_bone_Diseases_ppt_53b2d7a41eaab7802c07486b411b0859...
Osteomyelitis_Inflammatory_bone_Diseases_ppt_53b2d7a41eaab7802c07486b411b0859...Osteomyelitis_Inflammatory_bone_Diseases_ppt_53b2d7a41eaab7802c07486b411b0859...
Osteomyelitis_Inflammatory_bone_Diseases_ppt_53b2d7a41eaab7802c07486b411b0859...
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
Pyogenic bone and joint infections
Pyogenic bone and joint infectionsPyogenic bone and joint infections
Pyogenic bone and joint infections
 
Osteomyelities.pptx
Osteomyelities.pptxOsteomyelities.pptx
Osteomyelities.pptx
 
Osteomielitis
OsteomielitisOsteomielitis
Osteomielitis
 
Seminar on chronic osteomyelitis sch
Seminar on chronic osteomyelitis schSeminar on chronic osteomyelitis sch
Seminar on chronic osteomyelitis sch
 
Seminar on chronic osteomyelitis sch
Seminar on chronic osteomyelitis schSeminar on chronic osteomyelitis sch
Seminar on chronic osteomyelitis sch
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 

More from RebiraWorkineh

Roper_logan_tierney presentation by Rebira.pptx
Roper_logan_tierney presentation by Rebira.pptxRoper_logan_tierney presentation by Rebira.pptx
Roper_logan_tierney presentation by Rebira.pptxRebiraWorkineh
 
Nursing Theory Seminar presentation by Rebira
Nursing Theory Seminar presentation by RebiraNursing Theory Seminar presentation by Rebira
Nursing Theory Seminar presentation by RebiraRebiraWorkineh
 
Drugs for Schiezophrenia by Rebira Workineh.pptx
Drugs for Schiezophrenia by Rebira Workineh.pptxDrugs for Schiezophrenia by Rebira Workineh.pptx
Drugs for Schiezophrenia by Rebira Workineh.pptxRebiraWorkineh
 
Urinary Catheterization presentation by Rebira.pptx
Urinary Catheterization presentation by Rebira.pptxUrinary Catheterization presentation by Rebira.pptx
Urinary Catheterization presentation by Rebira.pptxRebiraWorkineh
 
7. constipation seminar presentation by Master Diriba pptx
7. constipation seminar presentation by Master Diriba pptx7. constipation seminar presentation by Master Diriba pptx
7. constipation seminar presentation by Master Diriba pptxRebiraWorkineh
 
Rebira Workineh Article Critical Appraisal.pptx
Rebira Workineh Article Critical Appraisal.pptxRebira Workineh Article Critical Appraisal.pptx
Rebira Workineh Article Critical Appraisal.pptxRebiraWorkineh
 
Hypertensive heart disease presentation.pptx
Hypertensive heart disease presentation.pptxHypertensive heart disease presentation.pptx
Hypertensive heart disease presentation.pptxRebiraWorkineh
 
Glaucoma Seminar Presentation by Rebira.pptx
Glaucoma  Seminar Presentation by Rebira.pptxGlaucoma  Seminar Presentation by Rebira.pptx
Glaucoma Seminar Presentation by Rebira.pptxRebiraWorkineh
 
Hernia Presentation presentation by Rebira pptx
Hernia Presentation presentation by Rebira pptxHernia Presentation presentation by Rebira pptx
Hernia Presentation presentation by Rebira pptxRebiraWorkineh
 
Wound Management Presentation by Rebira.pptx
Wound Management Presentation by Rebira.pptxWound Management Presentation by Rebira.pptx
Wound Management Presentation by Rebira.pptxRebiraWorkineh
 
Chronic Glomerulo Nephritis Presentation.pptx
Chronic Glomerulo Nephritis Presentation.pptxChronic Glomerulo Nephritis Presentation.pptx
Chronic Glomerulo Nephritis Presentation.pptxRebiraWorkineh
 
Hernia Presentation by Master Rebira W.pptx
Hernia Presentation by Master Rebira W.pptxHernia Presentation by Master Rebira W.pptx
Hernia Presentation by Master Rebira W.pptxRebiraWorkineh
 
Fluid and electrolyte by Dr. Dereje.pptx
Fluid and electrolyte by Dr. Dereje.pptxFluid and electrolyte by Dr. Dereje.pptx
Fluid and electrolyte by Dr. Dereje.pptxRebiraWorkineh
 
Rx of Thyrodism by Dr. Wako.2014.0028.pdf
Rx of Thyrodism by Dr. Wako.2014.0028.pdfRx of Thyrodism by Dr. Wako.2014.0028.pdf
Rx of Thyrodism by Dr. Wako.2014.0028.pdfRebiraWorkineh
 
COPD, asthma presentation by Mr. Getupdf
COPD, asthma presentation by Mr. GetupdfCOPD, asthma presentation by Mr. Getupdf
COPD, asthma presentation by Mr. GetupdfRebiraWorkineh
 
Capter-5 Medical surgical nursing II by Dr. Letapdf
Capter-5 Medical surgical nursing II by Dr. LetapdfCapter-5 Medical surgical nursing II by Dr. Letapdf
Capter-5 Medical surgical nursing II by Dr. LetapdfRebiraWorkineh
 
Stroke presentation by Dr. Alemayew 4.ppt
Stroke presentation by Dr. Alemayew 4.pptStroke presentation by Dr. Alemayew 4.ppt
Stroke presentation by Dr. Alemayew 4.pptRebiraWorkineh
 
2. Congestive heart failure by Dawit.pptx
2. Congestive heart failure by Dawit.pptx2. Congestive heart failure by Dawit.pptx
2. Congestive heart failure by Dawit.pptxRebiraWorkineh
 
Acute SDH Seminar Presentation by Rebira W..pptx
Acute SDH  Seminar Presentation by Rebira W..pptxAcute SDH  Seminar Presentation by Rebira W..pptx
Acute SDH Seminar Presentation by Rebira W..pptxRebiraWorkineh
 
Seminar Presentation On Appendicitis (1).pptx
Seminar Presentation On Appendicitis (1).pptxSeminar Presentation On Appendicitis (1).pptx
Seminar Presentation On Appendicitis (1).pptxRebiraWorkineh
 

More from RebiraWorkineh (20)

Roper_logan_tierney presentation by Rebira.pptx
Roper_logan_tierney presentation by Rebira.pptxRoper_logan_tierney presentation by Rebira.pptx
Roper_logan_tierney presentation by Rebira.pptx
 
Nursing Theory Seminar presentation by Rebira
Nursing Theory Seminar presentation by RebiraNursing Theory Seminar presentation by Rebira
Nursing Theory Seminar presentation by Rebira
 
Drugs for Schiezophrenia by Rebira Workineh.pptx
Drugs for Schiezophrenia by Rebira Workineh.pptxDrugs for Schiezophrenia by Rebira Workineh.pptx
Drugs for Schiezophrenia by Rebira Workineh.pptx
 
Urinary Catheterization presentation by Rebira.pptx
Urinary Catheterization presentation by Rebira.pptxUrinary Catheterization presentation by Rebira.pptx
Urinary Catheterization presentation by Rebira.pptx
 
7. constipation seminar presentation by Master Diriba pptx
7. constipation seminar presentation by Master Diriba pptx7. constipation seminar presentation by Master Diriba pptx
7. constipation seminar presentation by Master Diriba pptx
 
Rebira Workineh Article Critical Appraisal.pptx
Rebira Workineh Article Critical Appraisal.pptxRebira Workineh Article Critical Appraisal.pptx
Rebira Workineh Article Critical Appraisal.pptx
 
Hypertensive heart disease presentation.pptx
Hypertensive heart disease presentation.pptxHypertensive heart disease presentation.pptx
Hypertensive heart disease presentation.pptx
 
Glaucoma Seminar Presentation by Rebira.pptx
Glaucoma  Seminar Presentation by Rebira.pptxGlaucoma  Seminar Presentation by Rebira.pptx
Glaucoma Seminar Presentation by Rebira.pptx
 
Hernia Presentation presentation by Rebira pptx
Hernia Presentation presentation by Rebira pptxHernia Presentation presentation by Rebira pptx
Hernia Presentation presentation by Rebira pptx
 
Wound Management Presentation by Rebira.pptx
Wound Management Presentation by Rebira.pptxWound Management Presentation by Rebira.pptx
Wound Management Presentation by Rebira.pptx
 
Chronic Glomerulo Nephritis Presentation.pptx
Chronic Glomerulo Nephritis Presentation.pptxChronic Glomerulo Nephritis Presentation.pptx
Chronic Glomerulo Nephritis Presentation.pptx
 
Hernia Presentation by Master Rebira W.pptx
Hernia Presentation by Master Rebira W.pptxHernia Presentation by Master Rebira W.pptx
Hernia Presentation by Master Rebira W.pptx
 
Fluid and electrolyte by Dr. Dereje.pptx
Fluid and electrolyte by Dr. Dereje.pptxFluid and electrolyte by Dr. Dereje.pptx
Fluid and electrolyte by Dr. Dereje.pptx
 
Rx of Thyrodism by Dr. Wako.2014.0028.pdf
Rx of Thyrodism by Dr. Wako.2014.0028.pdfRx of Thyrodism by Dr. Wako.2014.0028.pdf
Rx of Thyrodism by Dr. Wako.2014.0028.pdf
 
COPD, asthma presentation by Mr. Getupdf
COPD, asthma presentation by Mr. GetupdfCOPD, asthma presentation by Mr. Getupdf
COPD, asthma presentation by Mr. Getupdf
 
Capter-5 Medical surgical nursing II by Dr. Letapdf
Capter-5 Medical surgical nursing II by Dr. LetapdfCapter-5 Medical surgical nursing II by Dr. Letapdf
Capter-5 Medical surgical nursing II by Dr. Letapdf
 
Stroke presentation by Dr. Alemayew 4.ppt
Stroke presentation by Dr. Alemayew 4.pptStroke presentation by Dr. Alemayew 4.ppt
Stroke presentation by Dr. Alemayew 4.ppt
 
2. Congestive heart failure by Dawit.pptx
2. Congestive heart failure by Dawit.pptx2. Congestive heart failure by Dawit.pptx
2. Congestive heart failure by Dawit.pptx
 
Acute SDH Seminar Presentation by Rebira W..pptx
Acute SDH  Seminar Presentation by Rebira W..pptxAcute SDH  Seminar Presentation by Rebira W..pptx
Acute SDH Seminar Presentation by Rebira W..pptx
 
Seminar Presentation On Appendicitis (1).pptx
Seminar Presentation On Appendicitis (1).pptxSeminar Presentation On Appendicitis (1).pptx
Seminar Presentation On Appendicitis (1).pptx
 

Recently uploaded

Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...M56BOOKSTORE PRODUCT/SERVICE
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxJiesonDelaCerna
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerunnathinaik
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...jaredbarbolino94
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,Virag Sontakke
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 

Recently uploaded (20)

Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptx
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developer
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 

Osteomyelitis, osteoarthritis, Rheumatoid arthritis.pdf

  • 2. Objectives 11/15/2022 By Getu M( Bsc, Msc) 2 At the end of the session the students will able to:  Describe osteomyelitis, osteo-arthritis, rheumatoid arthritis  Describe patho-physiology of osteomyelitis, osteo-arthritis, rheumatoid arthritis  List clinical features of osteomyelitis, osteo-arthritis, rheumatoid arthritis  Identify managements of osteomyelitis, osteo-arthritis, rheumatoid arthritis  Develop nursing process for the patients with osteomyelitis, osteo-arthritis, rheumatoid arthritis
  • 3. Osteomyelitis  Osteomyelitis is an infection of the bone. PATHOPHYSIOLOGY  Bone is normally resistant to infection.  When microorganisms are introduced into bone hematogenously from surrounding structures or from direct inoculation related to surgery or trauma, osteomyelitis can occur.  Bone infection may result from the treatment of trauma, which allows pathogens to enter bone and proliferate in the traumatized tissue. 11/15/2022 3
  • 4. Cont.…..  When bone infection persists for months, the resulting infection is referred to as chronic osteomyelitis and may be polymicrobial.  Although all bones are subject to infection, the lower extremity is most commonly involved. Important factors in the pathogenesis of osteomyelitis include the following:  Virulence of the infecting organism  Underlying disease  Immune status of the host  Type, location, and vascularity of the bone 11/15/2022 4
  • 5. Cont.……  Bacteria may possess various factors that may contribute to the development of osteomyelitis.  For example, factors promoted by S aureus may promote bacterial adherence, resistance to host defense mechanisms, and proteolytic activity 11/15/2022 5
  • 6. Cont.…… Hematogenous osteomyelitis  In adults, the vertebrae are the most common site of hematogenous osteomyelitis, but infection may also occur in the long bones, pelvis, and clavicle.  Primary hematogenous osteomyelitis is more common in infants and children, usually occurring in the long-bone metaphysis; it may spread to the medullary canal or into the joint.  Secondary hematogenous osteomyelitis is more common and can develop from any primary focus of infection or from reactivation of a previous infection in the presence of immuno-compromised status. 11/15/2022 6
  • 7. Contiguous-focus and posttraumatic osteomyelitis  The initiating factor in contiguous-focus osteomyelitis often consists of:  Direct inoculation of bacteria via trauma,  Surgical reduction and internal fixation of fractures, prosthetic devices,  Spread from soft-tissue infection,  Spread from adjacent septic arthritis, or nosocomial contamination.  Infection usually results approximately 1 month after inoculation. 11/15/2022 7
  • 8. Cont.……  Posttraumatic osteomyelitis more commonly affects adults and typically occurs in the tibia.  The most commonly isolated organism is S aureus.  At the same time, local soft-tissue vascularity may be compromised, leading to interference with healing.  Compared with hematogenous infection, posttraumatic infection begins outside the bony cortex and works its way in toward the medullary canal.  Low-grade fever, drainage, and pain may be present.  Loss of bone stability, necrosis, and soft-tissue damage may lead to a greater risk of recurrence 11/15/2022 8
  • 9. Cont.……  Septic arthritis may lead to osteomyelitis.  Abnormalities at the joint margins or centrally, which may arise from overgrowth and hypertrophy of the synovial pannus and granulation tissue,  may eventually extend into the underlying bone, leading to erosions and osteomyelitis.  One study demonstrated that septic arthritis in elderly persons most commonly involves the knee and that, despite most of the patients having a history of surgery, 38% developed osteomyelitis.  Many patients with vascular compromise, as in diabetes mellitus, are predisposed to osteomyelitis owing to an inadequate local tissue response 11/15/2022 9
  • 10. Cont.……  Infection in neuropathic or vascular-compromised feet is most often caused by minor trauma to the feet with multiple organisms isolated from bone,  including Streptococcus species, Enterococcus species, coagulase-positive and -negative staphylococci, gram-negative bacilli, and anaerobic organisms.  Fungal infections are also known in neuropathic feet with osteomyelitis.  Foot ulcers allow bacteria to reach the bone.  Patients may not experience any resulting pain, because of peripheral neuropathy, and may present with a perforating foot ulcer, cellulitis, or an ingrown toenail.  Treatment of osteomyelitis in diabetic feet is multidisciplinary and prolonged, involving complex debridements, soft-tissue cover, and antimicrobial and antifungal treatments. 11/15/2022 10
  • 11. Vertebral osteomyelitis  The incidence of vertebral osteomyelitis generally increases progressively with age, with most affected patients being older than 50 years  The infection usually originates hematogenously and generally involves two adjacent vertebrae with the corresponding intervertebral disk.  The lumbar spine is most commonly affected, followed by the thoracic and cervical regions.  Potential sources of infection include skin, soft tissue, respiratory tract, genitourinary tract, infected intravenous (IV) sites, and dental infections.  S aureus is the most commonly isolated organism.  However, Pseudomonas aeruginosa is more common in IV drug users. 11/15/2022 11
  • 12. Cont.……  Most patients with vertebral osteomyelitis present with localized pain and tenderness of the involved vertebrae with a slow progression over 3 weeks to 3 months.  Fever may be present in approximately 50% of patients.  Some 15% of patients may have motor and sensory deficits.  Laboratory studies may reveal peripheral leukocytosis and an elevated erythrocyte sedimentation rate (ESR).  Extension of the infection may lead to abscess formation. 11/15/2022 12
  • 13. Etiology  The major causes of osteomyelitis include the following:  Primary - Hematogenous  Secondary - Secondary to trauma, surgery, or sepsis of any etiology 11/15/2022 13
  • 14. Risk factors  Poorly nourished  Elderly  Obese  Impaired immune system (long-term corticosteroid therapy or immunosuppressive agents)  Chronic illness (diabetes, rheumatoid arthritis)  History of previous injury or infection  Postoperative 11/15/2022 14
  • 15. Epidemiology  Approximately 20% of adult cases of osteomyelitis are hematogenous, which is more common in males for unknown reasons.  The overall incidence of vertebral osteomyelitis is believed to have increased as a consequence of IV drug use, increasing age of the population, and higher rates of nosocomial infection due to intravascular devices and other instrumentation.  The overall incidence of osteomyelitis is higher in developing countries. 11/15/2022 15
  • 16. Presentation History  Acute osteomyelitis requires that the clinician maintain a high degree of suspicion so as to minimize delayed diagnosis and the consequences.  Osteomyelitis is often diagnosed clinically on the basis of nonspecific symptoms such as fever, chills, fatigue, lethargy, or irritability.  The classic signs of inflammation, including local pain, swelling, or redness, may also occur and usually disappear within 5-7 days 11/15/2022 16
  • 17. Cont.……  Chronic posttraumatic osteomyelitis requires a detailed history for diagnosis, including information regarding the initial injury and previous antibiotic and surgical treatment.  Weightbearing and function of the involved extremity are typically disturbed.  Local pain, swelling, erythema, and edema may also be reported 11/15/2022 17
  • 18. Physical examination  On physical examination, scars or local disturbance of wound healing may be noted along with the cardinal signs of inflammation.  Range of motion ROM), deformity, and local signs of impaired vascularity are also sought in the involved extremity 11/15/2022 18
  • 19. DIAGNOSTIC METHODS  A complete blood count (CBC) is useful for evaluating leukocytosis and anemia.  Leukocytosis is common in acute osteomyelitis before therapy. The leukocyte count rarely exceeds 15,000/µL acutely and is usually normal in chronic osteomyelitis.  The erythrocyte sedimentation rate (ESR) and the C-reactive protein (CRP) level are usually increased.  Alkaline phosphatase (ALP), calcium, and phosphate are elevated, but they are within normal limits in osteomyelitis. 11/15/2022 19
  • 20. Cont.……  Blood cultures are positive in only 50% of cases of osteomyelitis.  They should be obtained before or at least 48 hours after antibiotic treatment. 11/15/2022 20
  • 21. Imaging studies Radiography  Conventional radiography is the initial imaging study at presentation of acute osteomyelitis.  Radiographic findings include periosteal thickening or elevation, as well as cortical thickening, sclerosis, and irregularity.  Other changes include loss of trabecular architecture, osteolysis, and new bone formation.  These changes may not be evident until 5-7 days in children and 10-14 days in adults.  Plain films show lytic changes after at least 50-75% of the bone matrix is destroyed.  Therefore, negative radiographic studies do not exclude the diagnosis of acute osteomyelitis. 11/15/2022 21
  • 22. Cont.……  Computed tomography (CT) is useful for guiding needle biopsies in closed infections and for preoperative planning to detect osseous abnormalities, foreign bodies, or necrotic bone and soft tissue.  It may assist in the assessment of bony integrity, cortical disruption, and soft-tissue involvement. It may also reveal edema  Magnetic resonance imaging (MRI) is a very useful modality in detecting osteomyelitis and gauging the success of therapy because of its high sensitivity and excellent spatial resolution.  The extent and location of osteomyelitis is demonstrated along with pathologic changes of bone marrow and soft tissue 11/15/2022 22
  • 23. Cont.……  Bone biopsy leads to a definitive diagnosis by isolation of pathogens directly from the bone lesion.  Bone biopsy should be performed through uninfected tissue and either before the initiation of antibiotics or more than 48 hours after discontinuance.  Open or percutaneous needle bone biopsy with histopathologic examination and culture is the routine for the diagnosis of osteomyelitis.  This procedure may not be necessary if blood cultures are positive with consistent radiologic findings 11/15/2022 23
  • 24. Treatment  The principles of management of osteomyelitis necessitate a multipronged, multidisciplinary approach that may involve a team consisting of the following:  Orthopedic surgeon  Infectious disease consultant  Plastic surgeon  Microbiologist  Nurses  Others as needed 11/15/2022 24
  • 25. Cont.……  This approach should first determine whether the disease is acute, chronic, or an acute exacerbation of a chronic disease or (in some cases) a partially treated subacute osteomyelitis.  Acute osteomyelitis must be treated surgically to drain pus and prevent bone necrosis.  Antibiotics suited to the patient's age and the organism are given to control hematogenous spread and to treat the local infection.  In other words, antibiotics save life, and surgery helps save bone.  Debridement of necrotic tissues, removal of foreign materials, and sometimes skin closure of chronic unhealed wounds are necessary in some cases. 11/15/2022 25
  • 26. Differential Diagnoses  Ewing Sarcoma  Gout and Pseudogout  Septic Arthritis  Sickle Cell Disease (SCD) 11/15/2022 26
  • 27. Medical Therapy  Antibiotic treatment should be based on the identification of pathogens from bone cultures at the time of bone biopsy or debridement  Bone cultures are obtained first, and suspected pathogens are then covered by initiation of a parenteral antimicrobial treatment.  However, treatment may be modified once the organism is identified.  Parenteral and oral antibiotics may be used alone or in combination, depending on microorganism sensitivity results, patient compliance, and infectious disease consultation. 11/15/2022 27
  • 28. Cont.……  Traditionally, antibiotic treatment of osteomyelitis has consisted of a 4- to 6-week course.  Animal studies and observations show that bone revascularization following debridement takes about 4 weeks.  However, if all infected bone is removed, as in forefoot osteomyelitis, antibiotic therapy can be shortened to 10 days  Oral antibiotics that have been proved to be effective include clindamycin, rifampin, trimethoprim-sulfamethoxazole, and fluoroquinolones. 11/15/2022 28
  • 29. Cont.……  Clindamycin is given orally after initial intravenous (IV) treatment for 1-2 weeks and has excellent bioavailability.  It is active against most gram-positive bacteria, including staphylococci.  Linezolid is active against methicillin-resistant staphylococci and vancomycin-resistant Enterococcus.  It inhibits bacterial protein synthesis, has excellent bone penetration, and is administered IV or orally. 11/15/2022 29
  • 30. Cont.……  Oral quinolones are often used in adults for gram-negative organisms.  Quinolones have excellent oral absorption and may be used as soon as patient is able to take them.  Rifampin has an optimal intercellular concentration and a good sensitivity profile for methicillin-resistant staphylococci.  It is used in combination with cell wall–active antibiotics to achieve synergistic killing and to avoid rapid emergence of resistant strains. 11/15/2022 30
  • 31. Cont.……  The use of rifampin in combination with other antibiotics has been found to be more effective than monotherapy for treating infection associated with surgical hardware.  Extensive studies of suppressive therapy with administration of rifampin, ofloxacin, fusidic acid, and trimethoprim- sulfamethoxazole for 6-9 months have been performed in patients with infected orthopedic implants.  Studies have shown that, after discontinuance of antibiotics, no recurrence of infection occurred in 67% of patients treated with trimethoprim-sulfamethoxazole, 55% of patients treated with rifampin and fusidic acid, and 50% of patients treated with rifampin and ofloxacin. 11/15/2022 31
  • 32. Surgical Management  Surgical debridement of bone to remove purulent and necrotic material followed by irrigation is performed; IV antibiotics are continued.  Antibiotic-impregnated beads may be placed directly in the wound.  Chronic osteomyelitis: Sequestrectomy (removal of necrotic bone) is performed, with sufficient bone removed to convert a deep cavity into a shallow saucer (saucerization).  Closed suction irrigation system may be used to remove debris.  Wound irrigation using sterile physiologic saline solution may be performed for 7 to 8 days. 11/15/2022 32
  • 33. Cont.…..  Wounds are closed tightly to obliterate the dead space or packed and closed later by granulation or grafting with muscle flap.  Internal fixation or external supportive devices may be needed to stabilize or support the bone to prevent pathologic fracture. 11/15/2022 33
  • 34. Nursing process with patient with osteomyelitis Assessment  Assess for risk factors (eg, older age, diabetes, long-term steroid therapy) and for previous injury, infection, or orthopedic surgery.  Assess for acute onset of signs and symptoms (e.g. localized pain, edema, erythema, fever) or recurrent drainage of an infected sinus with associated pain, edema, and low- grade fever.  Observe for guarding or patient avoiding pressure on area. 11/15/2022 34
  • 35. Cont.…..  Assess for generalized weakness due to systemic reaction to infection.  Observe for inflammation, edema, tenderness, and purulent drainage.  Monitor for elevated temperature.  Patients with chronic osteomyelitis may have minimal temperature elevations, occurring in the afternoon or evening 11/15/2022 35
  • 36. Nursing Diagnoses  Acute pain related to inflammation and edema  Impaired physical mobility related to pain, immobilization devices, and weight-bearing limitations  Risk for extension of infection: Bone abscess formation  Deficient knowledge about treatment regimen 11/15/2022 36
  • 37. Planning  Goals include:-  Relief of pain,  Improved physical mobility within therapeutic limitations, control and  Eradication of infection, and knowledge of the treatment regimen. 11/15/2022 37
  • 38. Nursing Interventions Relieving Pain  Splint affected area to decrease pain and muscle spasm.  Monitor neurovascular status of affected extremity  Handle affected part with great care to avoid pain. • Elevate affected part to reduce swelling and discomfort. • Administer prescribed analgesics in conjunction with other techniques to reduce pain 11/15/2022 38
  • 39. Cont.….. Improving Physical Mobility  Teach patient to adhere to activity restrictions and reduce stress on the bone, as bone is weakened due to infectious process.  Encourage activities of daily living within physical limitations. 11/15/2022 39
  • 40. Cont.…..  Controlling Infectious Process • Monitor response to antibiotic therapy. Observe IV sites for evidence of phlebitis, infection, or infiltration. • Monitor for signs of super-infection, such as oral or vaginal candidiasis, and loose or foul-smelling stools, secondary to long-term antibiotic therapy. 11/15/2022 40
  • 41. Cont.…..  If surgery is necessary, maintain wound suction, elevation of area, avoidance of pressure on grafted area; maintain immobility and compliance with weight-bearing restrictions.  Change dressings using aseptic technique to promote healing and prevent cross-contamination.  Monitor general health and nutrition; provide a diet high in protein and vitamin C to promote positive nitrogen balance and healing; encourage adequate hydration 11/15/2022 41
  • 42. Cont.….. Teaching Patients Self-Care  Teach patient and family to adhere strictly to the antibiotics regimen and to prevent falls or other injuries that could result in fracture.  Teach patient and family how to maintain and manage the IV access site and IV administration equipment.  Provide education about medication name, dosage, frequency, administration rate, safe storage and handling, adverse reactions, and necessary laboratory monitoring. 11/15/2022 42
  • 43. Cont.…..  Teach about aseptic dressing and warm compress techniques.  Monitor for and instruct patient to report elevated temperature, drainage, odor, signs of increased inflammation, adverse reactions, and signs of super- infection.  Assess need for home care or home infusion.  Stress importance of follow-up health care appointments and recommend age-appropriate health screening 11/15/2022 43
  • 44. Evaluation Expected Patient Outcomes • Experiences pain relief • Increases physical mobility • Has absence of infection; negative wound cultures, normalWBCs • Adheres to therapeutic plan 11/15/2022 44
  • 45. Osteoarthritis  Osteoarthritis (OA) is the most common type of arthritis.  Its high prevalence, especially in the elderly, and its negative impact on physical function make it a leading cause of disability in the elderly  OA has been classified as primary (idiopathic), with no prior event or disease related to the OA, and secondary, resulting from previous joint injury or inflammatory disease.  The distinction between primary and secondary OA is not always clear. 11/15/2022 45
  • 46. Cont.……. Commonly affected joints include  The hip, knee, and first metatarsal phalangeal joint (MTP) and cervical and lumbosacral spine.  In the hands, the distal and proximal inter-phalangeal joints and the base of the thumb are often affected.  Usually spared are the wrist, elbow, and ankle.  OA often begins in the third decade of life and peaks between the fifth and sixth decades. 11/15/2022 46
  • 47. Joints commonly affected by osteoarthritis 11/15/2022 47
  • 48. Epidemiology  Studies continue to illustrate the high prevalence of OA worldwide, with a greater burden among:-  older individuals, women, some racial and ethnic groups, and individuals with lower socioeconomic status  Statistical figures are influenced by how the condition is defined— that is, by self-report, by radiographic or symptomatic criteria, or by a combination of these.  On the basis of the radiographic criteria for osteoarthritis, more 50% of adults older than 65 years are affected by the disease.  Internationally, osteoarthritis is the most common articular disease.  Estimates of its frequency vary across different populations. 11/15/2022 48
  • 50. Age-related demographics  Primary osteoarthritis is a common disorder of the elderly, and patients may present asymptomatic.  Approximately 80-90% of individuals older than 65 years have evidence of radiographic primary osteoarthritis  The prevalence of the disease increases dramatically among persons older than 50 years.Why?  Because of age-related alterations in collagen and proteoglycans that decrease the tensile strength of the joint cartilage and because of a diminished nutrient supply to the cartilage 11/15/2022 50
  • 51. Sex related characteristics  In individuals older than 55 years, the prevalence of osteoarthritis is higher among women than among men.  Women are especially susceptible to osteoarthritis in the DIP joints of the fingers.  Women also have osteoarthritis of the knee joints more frequently than men do, with a female-to-male incidence ratio of 1.7:1.  Women are also more prone to erosive osteoarthritis, with a female-to-male ratio of about 12:1. 11/15/2022 51
  • 52. Race-related demographics  In persons older than 65 years, osteoarthritis is more common in whites than in blacks.  Knee osteoarthritis appears to be more common in black women than in other groups. 11/15/2022 52
  • 53. RISK FACTORS  Joint vulnerability and joint loading are the two major factors contributing to the development of OA.  On the one hand, a vulnerable joint whose protectors are dysfunctional can develop OA with minimal levels of loading, perhaps even levels encountered during everyday activities.  On the other hand, in a young joint with competent protectors, a major acute injury or long-term overloading is necessary to precipitate disease.  Risk factors for OA can be understood in terms of their effect either on joint vulnerability or on loading 11/15/2022 53
  • 54. Risk factors for osteoarthritis (OA) either contribute to the susceptibility of the joint (systemic factors or factors in the local joint environment) or increase risk by the load they put on the joint. Usually, a combination of loading and susceptibility factors is required to cause disease or its progression. 11/15/2022 54
  • 55. PATHOPHYSIOLOGY  OA falls into two major etiologic classes.  Primary (idiopathic) OA, the more common type, has no identifiable cause.  Secondary OA is associated with a known cause such as rheumatoid or another inflammatory arthritis, trauma, metabolic or endocrine disorders, and congenital factors  The old view of OA as a “wear-and-tear” or degenerative disease, largely focused on joint cartilage, has long been superseded by an appreciation of the dynamic nature of OA and that it represents a failure of the joint and surrounding tissues.  Some changes in the OA joint may reflect compensatory processes to maintain function in the face of ongoing joint destruction.  Not only biomechanical forces but also inflammatory, biochemical, and immunologic factors are involved. 11/15/2022 55
  • 56. Function, Structure, and Composition of Cartilage  Articular cartilage possesses viscoelastic properties that provide lubrication with motion, shock absorbency during rapid movements, and load support.  In synovial joints, articular cartilage is found between the synovial cavity on one side and a narrow layer of calcified tissue overlying subchondral bone on the other side  The layer of cartilage is narrow, with human medial femoral articular cartilage being approximately 2 to 3 mm thick.  Despite this, healthy articular cartilage in weight-bearing joints withstands millions of cycles of loading and unloading each year.  Cartilage is easily compressed, losing up to 40% of its original height when a load is applied. 11/15/2022 56
  • 57. Cont.…..  Compression increases the area of contact and disperses force more evenly to underlying bone, tendons ligaments, and muscles.  In addition, cartilage is almost frictionless, and together with its compressibility, this enables smooth movement in the joint, distributes load across joint tissues to prevent damage, and stabilizes the joint 11/15/2022 57
  • 58. Cont.…..  Normal cartilage turnover helps repair and restore cartilage in response to demands of joint loading and during physical activity.  In adults, cartilage chondrocyte metabolism is slow and is regulated by growth factors, including bone morphogenetic protein 2, insulin-like growth factor-1, and transforming growth factor, and by catabolism and proteolysis stimulated by matrix metalloproteinases (MMPs), tumor necrosis factor-α (TNF-α), interleukin-1, and other cytokines.  Tissue inhibitors of metalloproteinase (TIMP) also contribute to the balance by restraining the catabolic actions of MMPs.  If cartilage is injured, chondrocytes react by removing the damaged areas and increasing synthesis of matrix constituents to repair and restore cartilage 11/15/2022 58
  • 59. Cont.…..  Another component supporting healthy joints are the joint protective mechanisms,  such as muscles bridging the joint, sensory receptors in feedback loops to regulate muscle and tendon function, supporting ligaments, and subchondral bone that has shock-absorbent properties.  Finally, it is important to note that adult articular cartilage is avascular, with chondrocytes nourished by synovial fluid.  With movement and cyclic loading and unloading of joints, nutrients flow into the cartilage, whereas immobilization reduces nutrient supply.  This is one of the reasons that normal physical activity is beneficial for joint health. 11/15/2022 59
  • 60. Characteristics of osteoarthritis in the diarthrodial joint 11/15/2022 60
  • 61. Osteoarthritic Cartilage  Important contributors to the development of OA are local mechanical influences, genetic factors, inflammation, and aberrant chondrocyte function leading to loss of articular cartilage.  At a molecular level, OA pathophysiology involves the interplay of dozens, if not hundreds, of extracellular and intracellular molecules with roles including:  chondrocyte regulation, phenotypic changes, proteolytic degradation of cartilage components, and interactions between articular cartilage, underlying subchondral bone, and the joint synovium. 11/15/2022 61
  • 62. Cont.…..  OA most commonly begins with damage to articular cartilage, through trauma or other injury, excess joint loading from obesity or other reasons, or instability or injury of the joint that causes abnormal loading.  In response to cartilage damage, chondrocyte activity increases in an attempt to remove and repair the damage.  Depending on the degree of damage, the balance between breakdown and re-synthesis of cartilage can be lost, and a vicious cycle of increasing breakdown can lead to further cartilage loss and apoptosis of chondrocytes 11/15/2022 62
  • 63. Cont.…..  There is an increased appreciation of the role of tissues beyond cartilage, within the joint and surrounding it, subchondral bone.  Subchondral bone undergoes pathologic changes that may precede, coincide with, or follow damage to the articular cartilage.  In OA, subchondral bone releases vasoactive peptides and MMPs, and damage to subchondral bone may trigger further damage to articular cartilage.  Neovascularization and subsequent increased permeability of the adjacent cartilage occur and contributes further to cartilage loss.  Joint space narrowing resulting from loss of cartilage can lead to a painful and deformed joint. 11/15/2022 64
  • 64. Cont.…..  Remaining cartilage softens and develops fibrillations (vertical clefts into the cartilage), followed by splitting off more cartilage and exposure of underlying bone.  During this time, adjacent subchondral bone undergoes further pathologic changes, cartilage is eroded completely, leaving denuded subchondral bone, which becomes dense, smooth, and glistening (eburnation).  A more brittle, stiffer bone results, with decreased weight-bearing ability and development of sclerosis and microfractures.  New bone formations, or osteophytes, also appear at joint margins, distant from cartilage destruction and are thought to arise from local and humoral factors.  There is direct evidence that osteophytes can help stabilize osteoarthritic joints 11/15/2022 65
  • 65. Cont.…..  In the joint capsule and synovium, inflammatory changes and pathologic changes can occur.  Contributors to inflammation may include crystals or cartilage shards in synovial fluid.  Other possible players are interleukin-1, prostaglandin E2, TNF-α, and nitric oxide which are found in synovial fluid.  With inflammatory changes in the synovium, effusions and synovial thickening occur.  The pain of OA is not related to the destruction of cartilage but arises from the activation of nociceptive nerve endings within the joint by mechanical and chemical irritants.  OA pain may result from distension of the synovial capsule by increased joint fluid, microfracture, periosteal irritation, or damage to ligaments, synovium, or the meniscus. 11/15/2022 66
  • 66. SOURCES OF PAIN  Because healthy cartilage is aneural, cartilage loss alone in a joint is not accompanied by pain.  Thus, pain in OA likely arises from structures outside the cartilage.  Innervated structures in the joint include the synovium, ligaments, joint capsule, muscles, and subchondral bone.  Most of these are not visualized by x-ray, and the severity of x-ray changes in OA correlates poorly with pain severity.  However, in later stages of OA, loss of cartilage integrity accompanied by neurovascular invasion may contribute to pain 11/15/2022 67
  • 67. Diagnosis  The diagnosis of OA is made through history, physical examination, characteristic radiographic findings, and laboratory testing.  The major diagnostic goals are: 1. To discriminate between primary and secondary OA and 2. To clarify the joints involved, severity of joint involvement, and response to prior therapies, providing a basis for a treatment plan 11/15/2022 68
  • 68. Cont.…..  The American College of Rheumatology has published traditional diagnostic criteria and “decision trees” for OA diagnosis.  As with all guidelines, the authors stress these are for assisting the clinician rather than replacing clinical judgment.  For example, traditional criteria are as follows:  (1) For hip OA, a patient must have pain in the hip and at least two of the following three: an erythrocyte sedimentation rate less than 20 mm/h (<5.6 µm/s), femoral or acetabular osteophytes on radiography, or joint space narrowing on radiography.  This provides a sensitivity of 89% and a specificity of 91%. 11/15/2022 69
  • 69. Cont.….. 2. For a clinical diagnosis of knee OA, a patient must have  Pain at the knee and osteophytes on radiography  Plus one of the following: age older than 50 years, morning stiffness not more than 30 minutes, crepitus on motion, bony enlargement, bony tenderness, or palpable warmth.  This provides a sensitivity of 95% and a specificity of 69%.  The addition of laboratory or radiographic data further improves accuracy of diagnosis 11/15/2022 70
  • 70. Clinical features Symptoms  Pain  Deep, aching character  Pain on motion  Stiffness in affected joints  Resolves with motion, recurs with rest (“gelling phenomenon”)  Usually duration <30 minutes  Often related to weather  Limited joint motion  May result in limitations of activities of daily living  Instability of weight-bearing joints Signs, history, and physical examination  Monoarticular or oligoarticular, asymmetrical involvement  Hands  Distal interphalangeal joints Herberden nodes (osteophytes or bony enlargements)  Proximal interphalangeal joints Bouchard’s nodes (osteophytes) First metacarpal joint  Osteophytes give characteristic square appearance to hands 11/15/2022 71
  • 71. Cont.…..  Knee Pain related to climbing stairs Transient joint effusion Genu varum (“bow-legged”)  Hips Groin pain during weight bearing exercises Stiffness, especially after activity Limited joint movement  Spine Lumbar involvement is most common at L3 and L4 Paresthesias Loss of reflexes  Feet Typically involves the first metatarsalphalangeal joint Shoulder, elbow, acromioclavicular, sternoclavicular, tempomandibular joints may also be affected  Observation on joint examination Bony proliferation or occasional synovitis Local tenderness Crepitus Limited motion with passive/active movement Deformity 11/15/2022 72
  • 72. Cont.…..  Radiologic Evaluation  Early Mild OA  Radiographic changes often absent  Progressive OA  Joint space narrowing  Subchondral bone sclerosis  Marginal osteophytes  Late OA Abnormal alignment of joints Effusions 11/15/2022 73
  • 73. Desired Outcome  Management of the patient with OA begins with a diagnosis based on a careful history, physical examination, radiographic findings, and an assessment of the extent of joint involvement.  Treatment should be tailored to each individual. Goals are A. To educate the patient, family members, and caregivers; B. To relieve pain and stiffness; C. To maintain or improve joint mobility; D. To limit functional impairment; and E. To maintain or improve quality of life 11/15/2022 74
  • 74. Treatment  Non pharmacologic – Encourage weight reduction if obese or overweight – Increase physical activity, specific exercise, physiotherapy – Weight supports (crutches, walking sticks or frames) – Arthroscopic interventions (irrigations, debridement and synovectomy) in refractory cases 11/15/2022 75
  • 77. Pharmacologic treatment Pain management Inflammatory osteoarthritis First line-NSAIDS,  Ibuprofen, 200-400mg P.O.,TID  Diclofenac, 50-75mg P.O., BID or rectal suppository 100mg/daily  Indomethacin, 25-50mg, P.O., 2-3 times/day; maximum dose is 200mg/day or rectal suppository 100mg/daily.  Avoid indomethacin in hip OA.  Piroxicam, 10-20mg, P.O., once per day. Maximum dose is 20mg/day  Dosage forms: Capsule, 10mg, 20mg ;Tablet, 10mg, 20mg  Meloxicam, 7.5-15mg/day. Maximum dose is 15 mg/day  Dosage forms:Tablet, 7.5mg, 15mg 11/15/2022 78
  • 78. Cont.…. Plus  GI protection for high risk individuals: a history of peptic ulcer disease, on antiplatelet therapy, concomitant anticoagulant therapy, or have more than one of other risk factors (Age ≥60 years, Corticosteroid use, Dyspepsia or GERD symptoms)  First line PPIs Omeprazole, 20mg, P.O., once daily or BID. Esomeprazole, 20-40mg, P.O., once daily Pantoprazole, 40mg, P.O., once daily  Alternative-H2 blockers Cimetidine, 400mg P.O., BID Ranitidine, 150mg, P.O, BID 11/15/2022 79
  • 79. Non inflammatory osteoarthritis  First line  Paracetamol, 1g 4–6 hourly P.O., when required to a maximum of 4 doses per 24 hours If ineffective: start NSAIDS as above.  First line  Tramadol, 50mg to 100mg, P.O., once to twice per day. Dosage forms: tablet/capsule, 50mg, 75mg, 100mg, 200mg  Alternative  Codeine phosphate 30mg P.O., QID. USE CODEINE FOR SHORT DURATION ONLY. Dosage forms: Tablet 30mg 11/15/2022 80
  • 80. Cont.….. Intra-articular steroids – Consider in inflammatory osteoarthritis of the knee and shoulder when it is refractory to NSAIDS – To be prescribed and administered by a specialist only – Not more than 2–3 injections per year per joint are recommended. First line Methylprednisolone acetate, 20–80mg depending on joint size  Dosage forms: Injection, 40mg/ml in 1ml ampoule 11/15/2022 81
  • 81. Cont.….. OR  Triamcinolone acetonide: Initial: Smaller joints: 2.5- 5mg, larger joints: 5-15mg, up to 40mg for large joints Dosage forms: Injection, 10mg/ml, 40mg/ml in vial 11/15/2022 82
  • 82. Rheumatoid arthritis  Rheumatoid arthritis (RA) is the most common systemic inflammatory disease characterized by symmetrical joint involvement.  Extra-articular involvement, including rheumatoid nodules, vasculitis, eye inflammation, neurologic dysfunction, cardiopulmonary disease, lymphadenopathy, and splenomegaly, can be manifestations of the disease. 11/15/2022 83
  • 83. Epidemiology  RA affects ∼0.5–1% of the adult population worldwide  It can occur at any age, with increasing prevalence up to the seventh decade of life.  The disease is three times more common in women.  In people aged 15 to 45 years, women predominate by a ratio of 6:1; the sex ratio is approximately equal among patients in the first decade of life and in those older than 60 years. 11/15/2022 84
  • 84. Cont.…….  Epidemiologic data suggest that a genetic predisposition and exposure to unknown environmental factors may be necessary for expression of the disease.  The major histocompatibility complex molecules, located on T lymphocytes, appear to have an important role in most patients with RA.  These molecules can be characterized using human lymphocyte antigen (HLA) typing.  A majority of patients with RA have HLA-DR4, HLA-DR1, or both antigens in the major histocompatibility complex region.  Patients with HLA-DR4 antigen are 3.5 times more likely to develop RA than those patients who have other HLA-DR antigens 11/15/2022 85
  • 85. Patho-physiology  In RA, the autoimmune reaction primarily occurs in the synovial tissue.  Phagocytosis produces enzymes within the joint.  The enzymes break down collagen, causing edema, proliferation of the synovial membrane, and ultimately pannus formation.  Pannus destroys cartilage and erodes the bone.  The consequence is loss of articular surfaces and joint motion.  Muscle fibers undergo degenerative changes.  Tendon and ligament elasticity and contractile power are lost 11/15/2022 86
  • 86. Pathophysiology and associated physical signs of rheumatoid arthritis. ROM, range of motion. 11/15/2022 87
  • 87. RISK FACTORS  Autoimmune  RA affects 1% of the population worldwide, affecting women two to four times more often than men 11/15/2022 88
  • 88. Clinical features  The incidence of RA increases between 25 and 55 years of age, after which it plateaus until the age of 75 and then decreases.  The presenting symptoms of RA typically result from inflammation of the joints, tendons, and bursae.  Patients often complain of early morning joint stiffness lasting >1 hour that eases with physical activity.  The earliest involved joints are typically the small joints of the hands and feet.  The initial pattern of joint involvement may be monoarticular, oligoarticular (≤4 joints), or polyarticular (>5 joints), usually in a symmetric distribution.  Some patients with inflammatory arthritis will present with too few affected joints to be classified as having RA so-called undifferentiated inflammatory arthritis. 11/15/2022 89
  • 89. Extra articular manifestations  Extra articular manifestations may develop during the clinical course of RA in up to 40% of patients, even prior to the onset of arthritis.  Patients most likely to develop extraarticular disease have a history of cigarette smoking, have early onset of significant physical disability, and test positive for serum RF or Anti-Citrullinated Protein Antibody (ACPA).  Subcutaneous nodules, secondary Sjögren’s syndrome, interstitial lung disease (ILD), pulmonary nodules, and anemia are among the most frequently observed extraarticular manifestations. 11/15/2022 90
  • 91. Cont.……  Subcutaneous nodules have been reported to occur in 30–40% of patients and more commonly in those with the highest levels of disease activity, the disease-related shared epitope (SE), a positive test for serum RF, and radiographic evidence of joint erosions.  Secondary Sjögren’s syndrome is defined by the presence of either keratoconjunctivitis sicca (dry eyes) or xerostomia (dry mouth) in association with another connective tissue disease, such as RA.  Approximately 10% of patients with RA have secondary Sjögren’s syndrome 11/15/2022 92
  • 92. Cont.…..  Pleuritis, the most common pulmonary manifestation of RA, may produce pleuritic chest pain and dyspnea, as well as a pleural friction rub and effusion.  The most frequent site of cardiac involvement in RA is the pericardium.  Up to 20% of patients with RA may have asymptomatic pericardial effusions on echocardiography.  Cardiomyopathy, another clinically important manifestation of RA, may result from necrotizing or granulomatous myocarditis, coronary artery disease, or diastolic dysfunction 11/15/2022 93
  • 93. Cont.…..  Rheumatoid vasculitis typically occurs in patients with long-standing disease, a positive test for serum RF or anti– cyclic citrullinated peptide (CCP) antibodies, and hypocomplementemia  A normochromic, normocytic anemia often develops in patients with RA and is the most common hematologic abnormality.  The degree of anemia parallels the degree of inflammation, correlating with the levels of serum C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).  Platelet counts may also be elevated in RA as an acute-phase reactant.  Immune-mediated thrombocytopenia is rare in this disease. 11/15/2022 94
  • 94. Cont.…..  Felty’s syndrome is defined by the clinical triad of neutropenia, splenomegaly, and nodular RA and is seen in <1% of patients  It typically occurs in the late stages of severe RA and is more common in whites than other racial groups.  Large cohort studies have shown a two- to fourfold increased risk of lymphoma in RA patients compared with the general population.  The most common histopathologic type of lymphoma is a diffuse large Bcell lymphoma.  The risk of developing lymphoma increases if the patient has high levels of disease activity or Felty’s syndrome. 11/15/2022 95
  • 95. Cont.…..  Osteoporosis is more common in patients with RA than an age- and sex-matched population, with an incidence rate of nearly double that of the healthy population and a prevalence of approximately one-third in postmenopausal women with RA 11/15/2022 96
  • 96. Investigations - ESR/CRP - Rheumatoid factor - ANA (antinuclear antibody) - X-ray of involved joints 11/15/2022 97
  • 97. Treatment  Objectives - Reduce pain, swelling and stiffness - Prevent deformities - Delay disease progression and onset of long term complications 11/15/2022 98
  • 98. Treatment  Non pharmacologic - Rest of affected joints during acute flares - Physiotherapy 11/15/2022 99
  • 99. Pharmacologic  Disease-modifying anti-rheumatic medicines (DMARD): Initiate early in the course First line Methotrexate, 7.5mg P.O., once per week. Increase dose gradually to a maximum of 25mg per week. N.B. Monitor: Liver function and CBC before and 12 weekly during treatment. PLUS Folic acid, 5mg P.O., per week with methotrexate at least 24 hours after the methotrexate dose 11/15/2022 100
  • 100. Cont.….. AND/OR  Chloroquine phosphate, 150mg P.O., (as base) daily for 5 days of each week for 2–3 months.  Then reduce dose if possible and administer 5 days a week with an annual medicine holiday for 1 month.  Do ophthalmic examination annually to monitor for ocular damage. AND/OR Sulfasalazine, 500mg P.O., 12 hourly. Gradually increase over one month from 500mg to 1 g 12 hourly.  Liver function and CBCs monthly for first 3 months then every 3–6 months 11/15/2022 101
  • 101. Cont.…..  Oral corticosteroids Indications: - As bridging therapy while waiting for DMARDs to take effect. - The elderly if threatened by functional dependence and intolerant to NSAIDs. - Extra-articular manifestations, e.g. pleural effusion, scleritis. - Acute flare Prednisolone, 40mg P.O., daily for 2 weeks during acute flares.  Thereafter gradually reduce the dose to < 7.5 mg daily.  Maintenance low dose prednisolone may be needed in many patients 11/15/2022 102
  • 102. Joint pain management-NSAIDs Use for active inflammation with pain. NSAIDs are used for symptomatic control only, as they have no long-term disease modifying effects. NSAID dose should be reduced and then stopped once the DMARDs have taken effect. Ibuprofen, 800mg, P.O.,TID with meals. If not tolerated: 400mg 8 hourly. An extra night-time dose of a NSAID may be added in some patients with severe nocturnal pain/morning stiffness OR 11/15/2022 103
  • 103. Cont.…..  Diclofenac, Immediate or delayed release tablet: 150- 200mg/day P.O., in 2-4 divided doses.  Rectal suppository, insert 50mg or 100 mg rectally as single dose to substitute for final daily dose (maximum combined dose [rectal and oral]: 150 mg/day) OR Indomethacin, 25-50mg P.O., BIDTO TID; maximum dose: 200mg/day. Rectal suppository, insert 100mg, BID or once, at bed time 11/15/2022 104